Clinical Trials Directory

Trials / Unknown

UnknownNCT05855590

Tranexamic Acid in Debridement Surgery of Burns on the Volume of Bleeding in Transfusion Requirements

Efficacy of Tranexamic Acid in Debridement Surgery of Burns on the Volume of Bleeding in Transfusion Requirements at Centro Medico de Occidente'

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Instituto Mexicano del Seguro Social · Other Government
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Tranexamic acid in debridement surgery of burns on the volume of bleeding in transfusion requirements

Detailed description

A randomized, double-blind, prospective trial was conducted to establish the effect of intraoperative tranexamic acid in the early surgical debridement of severe burns. The study was carried out between the months of January 2022 and December 2023.

Conditions

Interventions

TypeNameDescription
DRUGTranexamic acid10mg/kg intravenous single dose
OTHER0.9% isotonic saline solution100 ml intravenous single dose

Timeline

Start date
2022-01-01
Primary completion
2022-01-01
Completion
2023-12-30
First posted
2023-05-11
Last updated
2023-05-11

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT05855590. Inclusion in this directory is not an endorsement.

Tranexamic Acid in Debridement Surgery of Burns on the Volume of Bleeding in Transfusion Requirements (NCT05855590) · Clinical Trials Directory